Mabano, Concepcion P.
HRN: 20-30-99 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
04/21/2022
LEVOFLOXACIN 500MG (TAB)
04/21/2022
04/28/2022
PO
750mg
OD
Empirical Escalation
Waiting Final Action
Indication: Prophylaxis Type of Infection: Bloodstream Compliance to guidelines: Guideline Not Available
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes